<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Bioequivalence Tests for Parallel Trial Designs: 2 Arms, 3 Endpoints • SimTOST</title>
<!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.7.1/jquery.min.js" integrity="sha512-v2CJ7UaYy4JwqLDIrZUI/4hqeoQieOmAZNXBeQyjo21dadnwR+8ZaIJVT8EE2iyI61OV8e6M8PP2/4hpQINQ/g==" crossorigin="anonymous" referrerpolicy="no-referrer"></script><!-- Bootstrap --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/css/bootstrap.min.css" integrity="sha256-bZLfwXAP04zRMK2BjiO8iu9pf4FbLqX6zitd+tIvLhE=" crossorigin="anonymous">
<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script><!-- bootstrap-toc --><link rel="stylesheet" href="../bootstrap-toc.css">
<script src="../bootstrap-toc.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous">
<!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script><meta property="og:title" content="Bioequivalence Tests for Parallel Trial Designs: 2 Arms, 3 Endpoints">
<!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->
</head>
<body data-spy="scroll" data-target="#toc">


    <div class="container template-article">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">SimTOST</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="">0.3.0</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
<li>
  <a href="../reference/index.html">Reference</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    Articles

    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
<li>
      <a href="../articles/intopkg.html">Introduction</a>
    </li>
    <li>
      <a href="../articles/sampleSize_crossover.html">Bioequivalence Tests for 2x2 Cross-Over Trial Designs with Log-Normal Data</a>
    </li>
    <li>
      <a href="../articles/sampleSize_parallel_2A3E.html">Bioequivalence Tests for Parallel Trial Designs: 2 Arms, 3 Endpoints</a>
    </li>
    <li>
      <a href="../articles/sampleSize_parallel_3A1E.html">Bioequivalence Tests for Parallel Trial Designs: 3 Arms, 1 Endpoint</a>
    </li>
    <li>
      <a href="../articles/sampleSize_parallel.html">Bioequivalence Tests for Parallel Trial Designs with Log-Normal Data</a>
    </li>
  </ul>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul>
<ul class="nav navbar-nav navbar-right">
<li>
  <a href="https://github.com/smartdata-analysis-and-statistics/SimTOST/" class="external-link">
    <span class="fab fa-github fa-lg"></span>

  </a>
</li>
      </ul>
</div>
<!--/.nav-collapse -->
  </div>
<!--/.container -->
</div>
<!--/.navbar -->



      </header><script src="sampleSize_parallel_2A3E_files/kePrint-0.0.1/kePrint.js"></script><link href="sampleSize_parallel_2A3E_files/lightable-0.0.1/lightable.css" rel="stylesheet">
<div class="row">
  <div class="col-md-9 contents">
    <div class="page-header toc-ignore">
      <h1 data-toc-skip>Bioequivalence Tests for Parallel Trial Designs:
2 Arms, 3 Endpoints</h1>
                        <h4 data-toc-skip class="author">Thomas
Debray</h4>
            
            <h4 data-toc-skip class="date">January 08, 2025</h4>
      
      <small class="dont-index">Source: <a href="https://github.com/smartdata-analysis-and-statistics/SimTOST/blob/main/vignettes/sampleSize_parallel_2A3E.Rmd" class="external-link"><code>vignettes/sampleSize_parallel_2A3E.Rmd</code></a></small>
      <div class="hidden name"><code>sampleSize_parallel_2A3E.Rmd</code></div>

    </div>

    
    
<div class="section level2">
<h2 id="introduction">Introduction<a class="anchor" aria-label="anchor" href="#introduction"></a>
</h2>
<p>In many studies, it is necessary to evaluate equivalence across
multiple primary variables. For instance, the European Medicines Agency
(EMA) recommends demonstrating equivalence for both <strong>Area Under
the Curve</strong> (AUC) and <strong>maximum concentration</strong>
(Cmax) when assessing pharmacokinetic properties.</p>
<p>When multiple primary endpoints are involved, a decision must be made
on the desired criteria for equivalence:</p>
<ul>
<li>Equivalence for All Primary Endpoints
<ul>
<li>This is the most common setting and is often referred to as having
<em>multiple co-primary endpoints</em>.</li>
<li>Equivalence must be demonstrated for <strong>all</strong> endpoints
to conclude overall equivalence.</li>
</ul>
</li>
<li>Equivalence for At Least One Primary Endpoint
<ul>
<li>Known as having <em>multiple primary endpoints</em>.</li>
<li>Equivalence is required for <strong>at least one</strong> endpoint
to meet the study’s objectives.</li>
</ul>
</li>
</ul>
<p>This vignette presents advanced techniques for calculating sample
size in parallel trial designs involving three treatment arms and two
endpoints. Specifically, it focuses on bioequivalence testing between a
new treatment (SB2) and a reference drug (Remicade) administered in two
distinct locations (EU_Remicade and USA_Remicade).</p>
<p>As an illustrative example, we consider published data from the
phase-1 trial <a href="https://clinicaltrials.gov/study/NCT01922336#study-overview" class="external-link">NCT01922336</a>.
This trial assessed the pharmacokinetics of SB2 compared to its
EU-sourced reference product. The following outcomes were reported
following a single dose of SB2 or its EU reference product <span class="citation">(<a href="#ref-shin_randomized_2015">Shin et al.
2015</a>)</span>:</p>
<table class="table table table-striped" style="margin-left: auto; margin-right: auto;">
<caption>
Primary PK measures between test and reference product. Data represent
arithmetic mean +- standard deviation.
</caption>
<thead><tr>
<th style="text-align:left;">
PK measure
</th>
<th style="text-align:left;">
SB2
</th>
<th style="text-align:left;">
Remicade (EU)
</th>
</tr></thead>
<tbody>
<tr>
<td style="text-align:left;">
AUCinf
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>μ</mi><annotation encoding="application/x-tex">\mu</annotation></semantics></math>g*h/mL)
</td>
<td style="text-align:left;">
38,703
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mo>±</mo><annotation encoding="application/x-tex">\pm</annotation></semantics></math>
11,114
</td>
<td style="text-align:left;">
39,360
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mo>±</mo><annotation encoding="application/x-tex">\pm</annotation></semantics></math>
12,332
</td>
</tr>
<tr>
<td style="text-align:left;">
AUClast
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>μ</mi><annotation encoding="application/x-tex">\mu</annotation></semantics></math>g*h/mL)
</td>
<td style="text-align:left;">
36,862
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mo>±</mo><annotation encoding="application/x-tex">\pm</annotation></semantics></math>
9133
</td>
<td style="text-align:left;">
37,022
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mo>±</mo><annotation encoding="application/x-tex">\pm</annotation></semantics></math>
9398
</td>
</tr>
<tr>
<td style="text-align:left;">
Cmax
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>μ</mi><annotation encoding="application/x-tex">\mu</annotation></semantics></math>g/mL)
</td>
<td style="text-align:left;">
127.0
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mo>±</mo><annotation encoding="application/x-tex">\pm</annotation></semantics></math>
16.9
</td>
<td style="text-align:left;">
126.2
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mo>±</mo><annotation encoding="application/x-tex">\pm</annotation></semantics></math>
17.9
</td>
</tr>
</tbody>
</table>
<p>In the sections below, we explore various strategies for determining
the sample size required for a parallel trial to demonstrate equivalence
across the three co-primary endpoints. These strategies are based on the
Ratio of Means (ROM) approach, with equivalence bounds set between 80%
and 125%.</p>
</div>
<div class="section level2">
<h2 id="independent-testing-of-pk-measures">Independent Testing of PK Measures<a class="anchor" aria-label="anchor" href="#independent-testing-of-pk-measures"></a>
</h2>
<p>A conservative approach to sample size calculation involves testing
each pharmacokinetic (PK) measure independently. This method assumes
that the endpoints are uncorrelated and that equivalence must be
demonstrated for each endpoint separately. Consequently, the overall
sample size required for the trial is the sum of the sample sizes for
each PK measure.</p>
<div class="sourceCode" id="cb1"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="kw"><a href="https://rdrr.io/r/base/library.html" class="external-link">library</a></span><span class="op">(</span><span class="va"><a href="https://github.com/smartdata-analysis-and-statistics/SimTOST" class="external-link">SimTOST</a></span><span class="op">)</span></span>
<span></span>
<span><span class="co"># Sample size calculation for AUCinf</span></span>
<span><span class="op">(</span><span class="va">sim_AUCinf</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/sampleSize.html">sampleSize</a></span><span class="op">(</span></span>
<span>  power <span class="op">=</span> <span class="fl">0.9</span>,                                <span class="co"># Target power</span></span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,                               <span class="co"># Significance level</span></span>
<span>  arm_names <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"SB2"</span>, <span class="st">"EU_Remicade"</span><span class="op">)</span>,        <span class="co"># Names of trial arms</span></span>
<span>  list_comparator <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span><span class="st">"EMA"</span> <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"SB2"</span>, <span class="st">"EU_Remicade"</span><span class="op">)</span><span class="op">)</span>,  <span class="co"># Comparator configuration</span></span>
<span>  mu_list <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span><span class="st">"SB2"</span> <span class="op">=</span> <span class="fl">38703</span>, <span class="st">"EU_Remicade"</span> <span class="op">=</span> <span class="fl">39360</span><span class="op">)</span>,     <span class="co"># Mean values</span></span>
<span>  sigma_list <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span><span class="st">"SB2"</span> <span class="op">=</span> <span class="fl">11114</span>, <span class="st">"EU_Remicade"</span> <span class="op">=</span> <span class="fl">12332</span><span class="op">)</span>,  <span class="co"># Standard deviation values</span></span>
<span>  list_lequi.tol <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span><span class="st">"EMA"</span> <span class="op">=</span> <span class="fl">0.80</span><span class="op">)</span>,        <span class="co"># Lower equivalence margin</span></span>
<span>  list_uequi.tol <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span><span class="st">"EMA"</span> <span class="op">=</span> <span class="fl">1.25</span><span class="op">)</span>,        <span class="co"># Upper equivalence margin</span></span>
<span>  ncores <span class="op">=</span> <span class="fl">1</span>,                                 <span class="co"># Number of computation cores</span></span>
<span>  nsim <span class="op">=</span> <span class="fl">1000</span>                                 <span class="co"># Number of stochastic simulations</span></span>
<span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt; Sample Size Calculation Results</span></span>
<span><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span><span class="co">#&gt; Study Design: parallel trial targeting 90% power with a 5% type-I error.</span></span>
<span><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span><span class="co">#&gt;                  Parameter       Value</span></span>
<span><span class="co">#&gt;          Total Sample Size          78</span></span>
<span><span class="co">#&gt;             Achieved Power        90.5</span></span>
<span><span class="co">#&gt;  Power Confidence Interval 88.5 - 92.2</span></span>
<span></span>
<span><span class="co"># Sample size calculation for AUClast</span></span>
<span><span class="op">(</span><span class="va">sim_AUClast</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/sampleSize.html">sampleSize</a></span><span class="op">(</span></span>
<span>  power <span class="op">=</span> <span class="fl">0.9</span>,                                <span class="co"># Target power</span></span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,                               <span class="co"># Significance level</span></span>
<span>  arm_names <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"SB2"</span>, <span class="st">"EU_Remicade"</span><span class="op">)</span>,        <span class="co"># Names of trial arms</span></span>
<span>  list_comparator <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span><span class="st">"EMA"</span> <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"SB2"</span>, <span class="st">"EU_Remicade"</span><span class="op">)</span><span class="op">)</span>,  <span class="co"># Comparator configuration</span></span>
<span>  mu_list <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span><span class="st">"SB2"</span> <span class="op">=</span> <span class="fl">36862</span>, <span class="st">"EU_Remicade"</span> <span class="op">=</span> <span class="fl">37022</span><span class="op">)</span>,     <span class="co"># Mean values</span></span>
<span>  sigma_list <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span><span class="st">"SB2"</span> <span class="op">=</span> <span class="fl">9133</span>, <span class="st">"EU_Remicade"</span> <span class="op">=</span> <span class="fl">9398</span><span class="op">)</span>,    <span class="co"># Standard deviation values</span></span>
<span>  list_lequi.tol <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span><span class="st">"EMA"</span> <span class="op">=</span> <span class="fl">0.80</span><span class="op">)</span>,        <span class="co"># Lower equivalence margin</span></span>
<span>  list_uequi.tol <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span><span class="st">"EMA"</span> <span class="op">=</span> <span class="fl">1.25</span><span class="op">)</span>,        <span class="co"># Upper equivalence margin</span></span>
<span>  ncores <span class="op">=</span> <span class="fl">1</span>,                                 <span class="co"># Number of computation cores</span></span>
<span>  nsim <span class="op">=</span> <span class="fl">1000</span>                                 <span class="co"># Number of stochastic simulations</span></span>
<span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt; Sample Size Calculation Results</span></span>
<span><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span><span class="co">#&gt; Study Design: parallel trial targeting 90% power with a 5% type-I error.</span></span>
<span><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span><span class="co">#&gt;                  Parameter       Value</span></span>
<span><span class="co">#&gt;          Total Sample Size          54</span></span>
<span><span class="co">#&gt;             Achieved Power        90.4</span></span>
<span><span class="co">#&gt;  Power Confidence Interval 88.4 - 92.1</span></span>
<span></span>
<span></span>
<span><span class="co"># Sample size calculation for Cmax</span></span>
<span><span class="op">(</span><span class="va">sim_Cmax</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/sampleSize.html">sampleSize</a></span><span class="op">(</span></span>
<span>  power <span class="op">=</span> <span class="fl">0.9</span>,                                <span class="co"># Target power</span></span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,                               <span class="co"># Significance level</span></span>
<span>  arm_names <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"SB2"</span>, <span class="st">"EU_Remicade"</span><span class="op">)</span>,        <span class="co"># Names of trial arms</span></span>
<span>  list_comparator <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span><span class="st">"EMA"</span> <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"SB2"</span>, <span class="st">"EU_Remicade"</span><span class="op">)</span><span class="op">)</span>,  <span class="co"># Comparator configuration</span></span>
<span>  mu_list <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span><span class="st">"SB2"</span> <span class="op">=</span> <span class="fl">127.0</span>, <span class="st">"EU_Remicade"</span> <span class="op">=</span> <span class="fl">126.2</span><span class="op">)</span>,     <span class="co"># Mean values</span></span>
<span>  sigma_list <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span><span class="st">"SB2"</span> <span class="op">=</span> <span class="fl">16.9</span>, <span class="st">"EU_Remicade"</span> <span class="op">=</span> <span class="fl">17.9</span><span class="op">)</span>,    <span class="co"># Standard deviation values</span></span>
<span>  list_lequi.tol <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span><span class="st">"EMA"</span> <span class="op">=</span> <span class="fl">0.80</span><span class="op">)</span>,        <span class="co"># Lower equivalence margin</span></span>
<span>  list_uequi.tol <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span><span class="st">"EMA"</span> <span class="op">=</span> <span class="fl">1.25</span><span class="op">)</span>,        <span class="co"># Upper equivalence margin</span></span>
<span>  ncores <span class="op">=</span> <span class="fl">1</span>,                                 <span class="co"># Number of computation cores</span></span>
<span>  nsim <span class="op">=</span> <span class="fl">1000</span>                                 <span class="co"># Number of stochastic simulations</span></span>
<span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt; Sample Size Calculation Results</span></span>
<span><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span><span class="co">#&gt; Study Design: parallel trial targeting 90% power with a 5% type-I error.</span></span>
<span><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span><span class="co">#&gt;                  Parameter       Value</span></span>
<span><span class="co">#&gt;          Total Sample Size          18</span></span>
<span><span class="co">#&gt;             Achieved Power        91.2</span></span>
<span><span class="co">#&gt;  Power Confidence Interval 89.2 - 92.8</span></span></code></pre></div>
<p>If we were to test each PK measure independently, we would find a
total sample size of 78 for AUCinf, 54 for AUClast, and 18 for Cmax.
This means that we would have to enroll 78 + 54 + 18 = 150 patients in
order to reject
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>H</mi><mn>0</mn></msub><annotation encoding="application/x-tex">H_0</annotation></semantics></math>
at a significance level of 5%. For context, the original trial was a
randomized, single-blind, three-arm, parallel-group study conducted in
159 healthy subjects, slightly more than the 150 patients estimated as
necessary. This suggests that the original trial had a small buffer
above the calculated sample size requirements.</p>
</div>
<div class="section level2">
<h2 id="simultaneous-testing-of-pk-measures-with-independent-endpoints">Simultaneous Testing of PK Measures with Independent Endpoints<a class="anchor" aria-label="anchor" href="#simultaneous-testing-of-pk-measures-with-independent-endpoints"></a>
</h2>
<p>This approach focuses on simultaneous testing of pharmacokinetic (PK)
measures while assuming independence between endpoints. Unlike the
previous approach, which evaluated each PK measure independently, this
method integrates comparisons across multiple endpoints, accounting for
correlations (or lack thereof) between them. By doing so, it enables
simultaneous testing for equivalence without inflating the overall Type
I error rate.</p>
<p>In this setting, equivalence is required for at least one endpoint
rather than all endpoints, reducing the overall sample size compared to
independent testing. Furthermore, this approach allows for greater
flexibility by enabling users to specify correlation structures or work
with uncorrelated endpoints as a default assumption.</p>
</div>
<div class="section level2">
<h2 class="unnumbered" id="references">References<a class="anchor" aria-label="anchor" href="#references"></a>
</h2>
<div id="refs" class="references csl-bib-body hanging-indent" entry-spacing="0">
<div id="ref-shin_randomized_2015" class="csl-entry">
Shin, Donghoon, Youngdoe Kim, Yoo Seok Kim, Thomas Körnicke, and Rainard
Fuhr. 2015. <span>“A <span>Randomized</span>, <span>Phase I
Pharmacokinetic Study Comparing SB2</span> and <span>Infliximab
Reference Product</span> (<span>Remicade</span><span></span>) in
<span>Healthy Subjects</span>.”</span> <em>BioDrugs</em> 29 (6): 381–88.
<a href="https://doi.org/10.1007/s40259-015-0150-5" class="external-link">https://doi.org/10.1007/s40259-015-0150-5</a>.
</div>
</div>
</div>
  </div>

  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">

      </div>

</div>



      <footer><div class="copyright">
  <p></p>
<p>Developed by Thomas Debray, Johanna Muñoz, Dewi Amaliah, Biogen Inc.</p>
</div>

<div class="pkgdown">
  <p></p>
<p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.1.</p>
</div>

      </footer>
</div>






  </body>
</html>
